Influence of a selective 5HT1-receptor agonist GR43175 on platelet responsiveness |
| |
| Authors: | MG Tozzi-Ciancarelli C Di Massimo E Tozzi A Mascioli G De Matteis A Carolei |
| |
| Affiliation: | Laboratory of Applied Physiology, Department of S.T.B.B., School of Medicine, University of L'Aquila, L'Aquila, Italy;;Pediatric Clinic, Department of Experimental Medicine, School of Medicine, University of L'Aquila, L'Aquila, Italy;;Chair of Neurology, Headache Centre, School of Medicine, University of L'Aquila, L'Aquila, Italy |
| |
| Abstract: | The possible interaction of sumatriptan, a selective 5HT1-receptor agonist, with platelet responsiveness has been investigated. Stimulation of platelet rich plasma with sumatriptan (1–100 μM) did not induce shape change, aggregation or modification of intraplatelet cytosolic calcium levels. Total inhibition of aggregation induced by 20 μM 5HT was observed in platelets preincubated for 20 min with 100 μM sumatriptan. In the same model, platelet stimulation with 4 μM adenosine 5'-diphosphate (ADP), concentration known to induce an irreversible single-phase curve, determined a decrease of aggregatory response. Concentrations from I μM to 50 μM of sumatriptan did not influence the aggregatory response induced by 5HT and ADP. These effects appear not to be determined by modifications of platelet calcium homeostasis. The possibility to modulate platelet responsiveness by sumatriptan offers a further approach for evaluating the probable link between platelet behaviour and pathophysiology of migraine. |
| |
| Keywords: | 5HT platelet receptors cytosolic calcium human platelet aggregation sumatriptan |
|
|
